Abstract. Diallyl disulfide (DADS) has shown potential as a therapeutic agent in various cancers. Previously, calreticulin (CRT) was found to be downregulated in differentiated HL-60 cells treated with DADS. The present study investigated the role of CRT proteins in DADS-induced proliferation, invasion and differentiation in HL-60 cells. The present study demonstrated that DADS treatment significantly changed the morphology of HL-60 cells and caused the significant time-dependent downregulation of CRT. Small interfering RNA (siRNA)-mediated knockdown of CRT expression significantly inhibited proliferation, decreased invasion ability, increased the expression of cluster of differentiation (CD)11b and reduced the expression of CD33 in DADS-treated HL-60 cells. DADS also significantly affected cell proliferation, invasion and differentiation in CRT-overexpressed HL-60 cells. Nitroblue tetrazolium (NBT) reduction assays showed decreased NBT reduction activity in the CRT overexpression group and increased NBT reduction in the CRT siRNA group. Following treatment with DADS, the NBT reduction abilities in all groups were increased. In conclusion, the present study clearly demonstrates the downregulation of CRT during DADS-induced differentiation in HL-60 cells and indicates that CRT is involved in cell proliferation, invasion and differentiation in DADS-treated HL-60 cells.
IntroductionAcute myeloid leukemia (AML) is a genetically heterogeneous clonal disorder caused by the build up of somatic mutations in hematopoietic progenitor cells, which affects the regulation of self-renewal, survival, proliferation and differentiation (1).The induction of differentiation is a desired consequence of chemopreventive and therapeutic agents, as it often results in the elimination of premalignant or malignant cells (2). Numerous studies focus on selectively killing tumor cells through differentiation induction (3). Therefore, the development of novel differentiation-inducing drugs for blocking AML is of clinical significance.For the past 30 years, studies have explored the use of diallyl disulfide (DADS), the main active component of the cancer-fighting allyl sulfides found in garlic, as it has been shown to reduce the initiation of carcinogen-induced cancers and inhibit the proliferation of various types of cancer cells (4). The actions of DADS include the regulation of cell cycle arrest, induction of apoptosis and cell differentiation, and inhibition of cell invasion (5-7). Previous studies at the Cancer Research Institute, University of South China (Hengyang, China) confirmed that DADS can inhibit the proliferation of human leukemia cells in vivo in a dose-dependent manner (8,9). DADS exhibits a dual effect: A medium dose (>1.25 mg/l) can induce apoptosis in human leukemia cells (8,9), and a small dose (<1.25 mg/l) can induce human leukemia cell differentiation (2). The mechanisms of inducing differentiation involve: G 2 /M-phase cell cycle arrest; histone acetylation; the regulation of regulatory gene expression, including signa...